Search hospitals
>
California
>
Los Angeles
USC / Norris Comprehensive Cancer Center
Claim this profile
Los Angeles, California 90033
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Pancreatic Cancer
960 reported clinical trials
63 medical researchers
Summary
USC / Norris Comprehensive Cancer Center is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer and other specialties. USC / Norris Comprehensive Cancer Center is involved with conducting 960 clinical trials across 789 conditions. There are 63 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.
Area of expertise
Cancer
USC / Norris Comprehensive Cancer Center has run 185 trials for Cancer. Some of their research focus areas include:
Breast Cancer
USC / Norris Comprehensive Cancer Center has run 160 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Heinz-Josef Lenz
USC / Norris Comprehensive Cancer Center
8 years of reported clinical research
David Hong, MD
M D Anderson Cancer Center
4 years of reported clinical research
Jacob Thomas, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Clinical Trials running at USC / Norris Comprehensive Cancer Center
Breast Cancer
Skin Cancer
Bladder Cancer
Prostate Cancer
Cancer
Esophageal cancer
Colorectal Cancer
Lung Cancer
Kidney Cancer
Testicular cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting
2 awards
Phase 3
15 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at USC / Norris Comprehensive Cancer Center?
USC / Norris Comprehensive Cancer Center is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer and other specialties. USC / Norris Comprehensive Cancer Center is involved with conducting 960 clinical trials across 789 conditions. There are 63 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, David Hong, MD, and Jacob Thomas, MD.
Where is USC / Norris Comprehensive Cancer Center located?
**USC Norris Comprehensive Cancer Center Location and Access:** - Address: 1441 Eastlake Ave, Los Angeles, CA 90033. - By Car: Accessible via I-10 W or I-110 S, exit at Exposition Blvd, proceed north on S Park View St, and turn right onto Elaine Ave. - Public Transportation: For routes and schedules, refer to Moovit for guidance from your specific location.
Who should I call to ask about financial aid or insurance network?
For financial assistance at USC Norris Comprehensive Cancer Center, contact the Business Office at (323) 865-3000 or email uscnorrisinfo@med.usc.edu. For insurance inquiries, use the same contact details. The Financial Assistance Program at Keck Medicine of USC, including USC Norris Hospital, is reachable at (855) 532-5729 or through their website for more details and forms.
What insurance does USC / Norris Comprehensive Cancer Center accept?
The USC Norris Comprehensive Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna Healthcare, Anthem Blue Cross, Blue Shield of California, CIGNA, and United Healthcare. It's advised to verify benefits and network providers for specific products with your health plan, as not all providers participate in all health plan products or networks. The USC Trojan Care EPO and USC PPO plans specifically provide access to Keck Medicine of USC providers, including the USC Norris Comprehensive Cancer Center.
What awards or recognition has USC / Norris Comprehensive Cancer Center received?
The USC Norris Comprehensive Cancer Center, an NCI-designated comprehensive cancer center, is dedicated to reducing cancer health disparities in underserved communities, supported by a $25 million grant from The Ralph Lauren Corporate Foundation. It leads in cancer treatment and translates scientific discoveries into innovative therapies for patients.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.